Applications and limitations of radiomics
SSF Yip, HJWL Aerts - Physics in Medicine & Biology, 2016 - iopscience.iop.org
Radiomics is an emerging field in quantitative imaging that uses advanced imaging features
to objectively and quantitatively describe tumour phenotypes. Radiomic features have …
to objectively and quantitatively describe tumour phenotypes. Radiomic features have …
Predicting outcomes in radiation oncology—multifactorial decision support systems
P Lambin, RGPM Van Stiphout… - Nature reviews Clinical …, 2013 - nature.com
With the emergence of individualized medicine and the increasing amount and complexity of
available medical data, a growing need exists for the development of clinical decision …
available medical data, a growing need exists for the development of clinical decision …
[HTML][HTML] Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging …
SF Barrington, NG Mikhaeel, L Kostakoglu… - Journal of clinical …, 2014 - ncbi.nlm.nih.gov
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …
techniques have the potential to improve disease characterization and outcomes in …
Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients …
Background Cardiac positron emission tomography (PET) using 18 F-fluorodeoxyglucose
(FDG) has been used to diagnose and monitor cardiac sarcoidosis (CS). It is not known …
(FDG) has been used to diagnose and monitor cardiac sarcoidosis (CS). It is not known …
Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac …
EC Wicks, LJ Menezes, A Barnes… - European Heart …, 2018 - academic.oup.com
Aims Cardiac death is the leading cause of mortality in patients with sarcoidosis, yet cardiac
involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) …
involvement often remains undetected. Cardiovascular magnetic resonance imaging (CMR) …
[HTML][HTML] Feasibility of state of the art PET/CT systems performance harmonisation
A Kaalep, T Sera, S Rijnsdorp, M Yaqub… - European journal of …, 2018 - Springer
Purpose The objective of this study was to explore the feasibility of harmonising
performance for PET/CT systems equipped with time-of-flight (ToF) and resolution …
performance for PET/CT systems equipped with time-of-flight (ToF) and resolution …
Total-body quantitative parametric imaging of early kinetics of 18F-FDG
Parametric imaging has been shown to provide better quantitation physiologically than SUV
imaging in PET. With the increased sensitivity from a recently developed total-body PET …
imaging in PET. With the increased sensitivity from a recently developed total-body PET …
Decision support systems for personalized and participative radiation oncology
A paradigm shift from current population based medicine to personalized and participative
medicine is underway. This transition is being supported by the development of clinical …
medicine is underway. This transition is being supported by the development of clinical …
Towards enhanced PET quantification in clinical oncology
H Zaidi, N Karakatsanis - The British journal of radiology, 2017 - academic.oup.com
Positron emission tomography (PET) has, since its inception, established itself as the
imaging modality of choice for the in vivo quantitative assessment of molecular targets in a …
imaging modality of choice for the in vivo quantitative assessment of molecular targets in a …
Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy
M Kircher, S Ihne, J Brumberg, C Morbach… - European journal of …, 2019 - Springer
Purpose Cardiac amyloidosis (CA) is a rare cause of heart failure with frequently delayed
diagnosis, because specific early signs or symptoms are missing. Recently, direct amyloid …
diagnosis, because specific early signs or symptoms are missing. Recently, direct amyloid …